United States· US:69993-600_0fae7f5e-96e0-4745-be00-47c9c33ac07e
Blue-Emu Thrive Pain Relief Cream
A tripelennamine product containing tripelennamine, registered in United States by Kingsway Pharmaceuticals dba NFI, LLC. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Tripelennamine is registered in 4 of 19 countries.
Countries holding a registration under ATC D04AA04 (tripelennamine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Tripelennamine · ATC D04AA04
4 / 19 countries
- Finlandprice
- Germany
- Netherlands
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRIPELENNAMINE
- Manufacturer
- Kingsway Pharmaceuticals dba NFI, LLC
- Country
- United States (US)
- ATC code
- D04AA04
- ATC class
- Tripelennamine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11699936000385 g in 1 JAR (69993-600-03)
- ndc1169993-600-03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tripelennamine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainAZARON STICK 20 MG/G BARRA CUTÁNEAPerrigo Espana S.A.
- NetherlandsAzaron Stick, stift 20 mg/gOmega Pharma Nederland B.V.
- GermanyAzaronPerrigo Deutschland Gmbh
- FinlandEtonoPerrigo Sverige AB
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Azaron
- Spain · Relepost
- Finland · Etono
- Netherlands · Azaron, Azaron Stick
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6f893bd-72d7-4c25-bc0f-f8bf5a0e7b77 GET /v1/drugs/e6f893bd-72d7-4c25-bc0f-f8bf5a0e7b77?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".5",
"substance": "TRIPELENNAMINE",
"productndc": "69993-600",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/100g",
"application_number": "M017",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about tripelennamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.